लोड हो रहा है...

Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine

Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity. However the most important problem of lamivudine treatment is the emergence o...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Soudbakhsh A, Pouryasin A, Rafiei Tabatabaei R, Ehsani R, Sharafi H
स्वरूप: Artigo
भाषा:Persa
प्रकाशित: Qom University of Medical Sciences 2011-06-01
श्रृंखला:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
विषय:
ऑनलाइन पहुंच:http://journal.muq.ac.ir/library/upload/article/af_325292290.18.7.pdf
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!